Federal Register / Vol. 72, No. 232 / Tuesday, December 4, 2007 / Notices 68167 

5100 Paint Branch Pkwy., College Park, 

MD 20740–3835, 301–436–1264. 

SUPPLEMENTARY INFORMATION: Under the 

Federal Food, Drug, and Cosmetic Act 

(section 721e(d)(1) (21 U.S.C. 

379e(d)(1))), notice is given that a color 

additive petition (CAP 7C0284) has been 

filed by DSM Nutritional Products, Inc., 

45 Waterview Blvd., Parsippany, NJ 

07054. The petition proposes to amend 

the color additive regulations in 21 CFR 

part 73 to provide for the safe use of 

astaxanthin dimethyldisuccinate as a 

color additive in the feed of salmonid 

fish to enhance the color of their flesh. 

The agency has determined under 21 

CFR 25.32(r) that this action is of a type 

that does not individually or 

cumulatively have a significant effect on 

the human environment. Therefore, 

neither an environmental assessment 

nor an environmental impact statement 

is required. 

Dated: November 27, 2007. 

Laura M. Tarantino, 

Director, Office of Food Additive Safety, 

Center for Food Safety and Applied Nutrition. 

[FR Doc. E7–23473 Filed 12–3–07; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institutes of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Organ Specific Innate 

Immunity. 

Date: December 17, 2007. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Room 3146, Bethesda, MD 20817 (Telephone 

Conference Call). 

Contact Person: Kenneth E. Santora, PhD., 

Scientific Review Officer, Scientific Review 

Program, NIH/NIAID/DHHS, Room 3146, 

6700B Rockledge Drive, MSC 7616, Bethesda, 

MD 20892, 301–451–2605, ks216i@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitation imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: November 26, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5909 Filed 12–3–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel, MBRS—RISE and SCORE. 

Date: December 11, 2007. 

Time: 3 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892, (Telephone Conference Call). 

Contact Person: Lisa Dunbar, PhD., Office 

of Scientific Review, National Institute of 

General Medical Sciences, National Institutes 

of Health, 45 Center Drive, Room 3AN12, 

Bethesda, MD 20892, 301–594–2849, 

dunbarl@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and Development 

Biology Research; 93.88, Minority Access to 

Research Careers; 93.96, Special Minority 

Initiatives, National Institutes of Health, 

HHS) 

Dated: November 26, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5910 Filed 12–3–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Advisory Mental Health 

Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Mental Health Council. 

Date: January 10–11, 2008. 

Closed: January 10, 2008, 10 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and review the activities of the 

NIMH; Intramural Research Programs. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Conference Room C/D/E, 

Rockville, MD 20852. 

Open: January 11, 2008, 8:30 a.m. to 12:30 

p.m. 

Agenda: Presentation of NIMH Director’s 

report and discussion on NIMH program and 

policy issues. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C Wing, 6th 

Floor, Conference Room 6, Bethesda, MD 

20892. 

Contact Person: Jane A. Steinberg, PhD, 

Director, Division of Extramural Activities, 

mstockstill on PROD1PC66 with NOTICES